Plasma antioxidant factors in persons with different stages of obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Serum vitamin D, physical activity and the obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
Serum fibrinogen in patients with obstructive sleep apnea Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Relationship between NT-proBNP plasma level and nocturia in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
Plasma orexin-A levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Circulating survivin levels in patients with obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017
Relationships between obstructive sleep apnea and oxidant/antioxidant status Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
Serum resistin level in pediatric obstructive sleep apnea Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases Year: 2008
Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Influence of body weight on plasma NT-proBNP in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Low morning serum cortisol levels in children with adenotonsillar hypertrophy and obstructive sleep apnea Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children Year: 2012
Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017
Sexual function status in women with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 596s Year: 2005
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002